# FDA Inspection 846973 - Delta Blood Bank - September 04, 2013

Source: https://www.keypedia.com/records/fda_inspections/delta-blood-bank/1adfca7d-fe2e-4e34-8ed0-2bbdb8acecac
Source feed: FDA_Inspections

> FDA Inspection 846973 for Delta Blood Bank on September 04, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 846973
- Company Name: Delta Blood Bank
- Inspection Date: 2013-09-04
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 927674 - 2015-05-27](https://www.keypedia.com/records/fda_inspections/delta-blood-bank/1bdd5996-090a-4e6b-bb59-3d6e7fd136a2)
- [FDA Inspection 752097 - 2011-11-02](https://www.keypedia.com/records/fda_inspections/delta-blood-bank/85bfbeb6-1886-4a7b-a34e-92893b7a334b)
- [FDA Inspection 629338 - 2009-11-18](https://www.keypedia.com/records/fda_inspections/delta-blood-bank/a292bd66-8ddf-4a77-a199-833329df1ce8)

Company: https://www.keypedia.com/companies/delta-blood-bank/bea9ae93-9b43-4349-b516-d5592b87330f

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d